Results 91 to 100 of about 149 (149)
TagGen: Diffusion‐based generative model for cardiac MR tagging super resolution
Magnetic Resonance in Medicine, Volume 94, Issue 1, Page 362-372, July 2025.Abstract Purpose The aim of the work is to develop a cascaded diffusion‐based super‐resolution model for low‐resolution (LR) MR tagging acquisitions, which is integrated with parallel imaging to achieve highly accelerated MR tagging while enhancing the tag grid quality of low‐resolution images.
Changyu Sun +4 more
wiley +1 more source
Improving ungated steady‐state cardiac perfusion using transition bands
Magnetic Resonance in Medicine, Volume 94, Issue 1, Page 199-214, July 2025.Abstract Purpose Although gated first‐pass contrast‐enhanced sequences are the clinical standard for cardiovascular MR perfusion, some patient conditions necessitate using ungated steady‐state sequences. However, through‐plane cardiac motion and blood flow into the left ventricle can disrupt the magnetization steady state of the tissue, and perfusion ...
Jason K. Mendes +5 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2310-2320, June 2025.Abstract Background Chronic kidney disease (CKD) has a high prevalence in patients with heart failure (HF) and is associated with prolonged hospitalization, increased need for intensive care and mortality. There is an urgent need to identify factors that influence the interaction between heart and kidney disorders, often described as cardiorenal ...
Alexander Reinecke +7 more
wiley +1 more source
The Duration of the Ventricular Systole
Cardiology, 1950 Miller M, Franz M. Groedel
openaire +3 more sources
ESC Heart Failure, Volume 12, Issue 3, Page 1796-1806, June 2025.Abstract Aims Wild‐type transthyretin cardiac amyloidosis (ATTRwt) is a cardiomyopathy causing myocardial hypoperfusion and impaired cardiac mitochondrial function. Trimetazidine is an antianginal agent used in patients with stable angina pectoris, which improves cardiac contractility and mitochondrial function.
Bertil Thyrsted Ladefoged +5 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 1703-1713, June 2025.Abstract Aims Differences in guideline‐directed medical therapy (GDMT) and clinical outcomes have been observed between heart failure (HF) patients with atrial fibrillation (AF) versus those in sinus rhythm. This study evaluated the effects of up‐titration of HF therapies, consisting of beta‐blockers, angiotensin‐converting‐enzyme inhibitors (ACEis ...
Arietje J.L. Zandijk +6 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 1883-1892, June 2025.Abstract Aims Ischaemic mitral regurgitation (MR) is a dynamic condition influenced by global and regional left ventricular remodelling as well as mitral valvular deformation. Exercise testing plays a substantial role in assessing the haemodynamic relevance of MR and is recommended by current guidelines.
Maximilian Spieker +14 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 1942-1955, June 2025.Abstract Aims Patients with cardiomyopathies are a heterogeneous group of patients who experience high morbidity and mortality. Early cardiac assessment and intervention with access to genetic counselling in a multidisciplinary Cardiomyopathy Clinic may improve outcomes and prevent progression to advanced heart failure.
Chandu Sadasivan +12 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2023-2033, June 2025.Abstract Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure. We aimed to evaluate the impact on a worsening renal function (WRF) by adding DAPA as compared to standard decongestive therapy with loop diuretics alone.
Shodai Kawanami +11 more
wiley +1 more source